US 9744137
Topiramate compositions and methods of enhancing its bioavailability
granted A61KA61K31/357A61K9/1635
Quick answer
US patent 9744137 (Topiramate compositions and methods of enhancing its bioavailability) held by Supernus Pharmaceuticals, Inc. expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/357, A61K9/1635, A61K9/2013, A61K9/2054